Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4852038
Max Phase: Preclinical
Molecular Formula: C43H63NO4
Molecular Weight: 657.98
Molecule Type: Unknown
Associated Items:
ID: ALA4852038
Max Phase: Preclinical
Molecular Formula: C43H63NO4
Molecular Weight: 657.98
Molecule Type: Unknown
Associated Items:
Canonical SMILES: C=C(C)[C@@H]1CC[C@]2(COC(=O)c3ccccc3C(=O)N3CCCCC3)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12
Standard InChI: InChI=1S/C43H63NO4/c1-28(2)29-17-22-43(27-48-38(47)31-14-10-9-13-30(31)37(46)44-25-11-8-12-26-44)24-23-41(6)32(36(29)43)15-16-34-40(5)20-19-35(45)39(3,4)33(40)18-21-42(34,41)7/h9-10,13-14,29,32-36,45H,1,8,11-12,15-27H2,2-7H3/t29-,32+,33-,34+,35-,36+,40-,41+,42+,43+/m0/s1
Standard InChI Key: FAFUTRAKYCDUJQ-HLXGXBOOSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 657.98 | Molecular Weight (Monoisotopic): 657.4757 | AlogP: 9.49 | #Rotatable Bonds: 5 |
Polar Surface Area: 66.84 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: 2 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 8.81 | CX LogD: 8.81 |
Aromatic Rings: 1 | Heavy Atoms: 48 | QED Weighted: 0.25 | Np Likeness Score: 1.80 |
1. Pęcak P, Orzechowska B, Chrobak E, Boryczka S.. (2021) Novel betulin dicarboxylic acid ester derivatives as potent antiviral agents: Design, synthesis, biological evaluation, structure-activity relationship and in-silico study., 225 [PMID:34425312] [10.1016/j.ejmech.2021.113738] |
Source(1):